Lajme flash
Experts warn of rising poisonings linked to weight loss injections
2026-07-01 11:28:00 / MISTERE&KURIOZITETE
Reports of health problems linked to injectable weight-loss drugs have nearly doubled in the past year, raising concerns among medical professionals about the growing unsupervised use of powerful drugs and experimental treatments under development.
Healthcare professionals filed 149 reports in 2025 involving patients who had used injectable weight-loss drugs, compared with 76 reports in 2024, according to data from the Dutch National Poison Information Center (NVIC) at UMC Utrecht, Dutch broadcaster NOS reported today.
Officials believe the true number of cases is likely higher, as not all incidents are reported or officially linked to these drugs. A significant proportion of cases involve unprescribed or unsupervised use. About 40 percent of reports come from situations where patients have used drugs obtained outside regular medical channels.
Experts describe the trend as worrying, pointing to a growing market in which people are getting weight-loss injections online or through informal networks instead of from doctors. Drugs such as Ozempic were originally developed for type 2 diabetes and later approved for the treatment of obesity under medical supervision.
However, its rise in popularity on social media and celebrity endorsements have contributed to its widespread use among people without clinical guidance. Researchers warn that this shift from regulated to self-directed use increases the risk of incorrect dosing and side effects.
Recently, concerns have also grown about retatrutide, sometimes called "Triple G," an experimental weight-loss drug that has not yet been approved for prescription use in the Netherlands.
In 2025, the NVIC recorded six reports of poisonings linked to it, rising to 12 cases in the first five months of this year alone. Because the drug is not officially registered, it is not available through legal medical prescriptions, but can still be accessed through online marketplaces.
Medical toxicologists warn that so-called “potent variants” like retatrutide can carry high risks, especially when used without supervision. Overdose or misuse can lead to acute symptoms that require emergency care, including severe gastrointestinal reactions and metabolic complications.
Long-term concerns include possible damage to the liver, kidneys, and nervous system.
Po ndodh...
Rama's government no longer has enough Berisha!
Nga Indrit Gjyzeli
ide
top
TRENDING 
shërbime
- POLICIA129
- POLICIA RRUGORE126
- URGJENCA112
- ZJARRFIKESJA128